Fri, 09/27/2024 - 11:50 Gizmodo On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades. Tags health, Cobenfy, drug approvals, drug innovations, Schizophrenia Source FDA Approves Potentially Groundbreaking Schizophrenia Drug
